(Q38613525)

4 September 2017

title

Dysregulated miRNA in progression of hepatocellular carcinoma: A systematic review (English)

1 reference

4 September 2017

1 reference

hepatocellular carcinoma

1 reference

3

Hiroshi Yoshida

1 reference

4 September 2017

Yoshiaki Mizuguchi

1

1 reference

4 September 2017

Toshihiro Takizawa

series ordinal

2

1 reference

4 September 2017

Eiji Uchida

series ordinal

4

1 reference

4 September 2017

publication date

22 October 2015

1 reference

4 September 2017

1 reference

4 September 2017

volume

46

1 reference

4 September 2017

issue

5

1 reference

4 September 2017

page(s)

391-406

1 reference

Epidemiology and management of hepatocellular carcinoma.

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Bioinformatics analysis reveals potential candidate drugs for HCC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Hepatocellular carcinoma pathogenesis: from genes to environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Predictive power of biomarkers of oxidative stress and inflammation in patients with hepatitis C virus-associated hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Resveratrol suppresses oxidative stress and inflammatory response in diethylnitrosamine-initiated rat hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Induction of aneuploidy by increasing chromosomal instability during dedifferentiation of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNAs in vertebrate development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNAs in liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

miR-221 overexpression contributes to liver tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Sequencing and bioinformatics-based analyses of the microRNA transcriptome in hepatitis B-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA expression profiles classify human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Integrating contextual miRNA and protein signatures for diagnostic and treatment decisions in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNAs: Potential biomarkers in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Genomic analysis of human microRNA transcripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Intronic microRNA precursors that bypass Drosha processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Nuclear export of microRNA precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

A microRNA in a multiple-turnover RNAi enzyme complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNAs: small RNAs with a big role in gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Switching from repression to activation: microRNAs can up-regulate translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Posttranscriptional upregulation by microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

New class of microRNA targets containing simultaneous 5'-UTR and 3'-UTR interaction sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Identification of metastasis-related microRNAs in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

miR-21-mediated tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA-21: a novel therapeutic target in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

The transcriptional regulation of miR-21, its multiple transcripts, and their implication in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein kinase-kinase 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA-221 overexpression accelerates hepatocyte proliferation during liver regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

miR-221 silencing blocks hepatocellular carcinoma and promotes survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

The pivotal role of microRNA-155 in the control of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Liver-specific microRNA-122: Biogenesis and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MiR-122 in hepatic function and liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

miR-122 regulates hepatic lipid metabolism and tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Antitumor function of microRNA-122 against hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

miR-122--a key factor and therapeutic target in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

microRNAs: novel players in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

A liver-specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Hepatic loss of miR-122 predisposes mice to hepatobiliary cyst and hepatocellular carcinoma upon diethylnitrosamine exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

miR-122 acts as a tumor suppressor in hepatocarcinogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Downregulation of miR-101-3p by hepatitis B virus promotes proliferation and migration of hepatocellular carcinoma cells by targeting Rab5a

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA-101 suppresses SOX9-dependent tumorigenicity and promotes favorable prognosis of human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MiR-101 functions as a tumor suppressor by directly targeting nemo-like kinase in liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Loss of MicroRNA-101 Promotes Epithelial to Mesenchymal Transition in Hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MiR-200b/200c/429 subfamily negatively regulates Rho/ROCK signaling pathway to suppress hepatocellular carcinoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

microRNA-141 inhibits cell proliferation and invasion and promotes apoptosis by targeting hepatocyte nuclear factor-3β in hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

let-7 regulates self renewal and tumorigenicity of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Hsa-let-7g inhibits proliferation of hepatocellular carcinoma cells by downregulation of c-Myc and upregulation of p16(INK4A).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

The impact of miR-34a on protein output in hepatocellular carcinoma HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Clinical significance of microRNA 138 and cyclin D3 in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Hepatitis B virus inhibits apoptosis of hepatoma cells by sponging the MicroRNA 15a/16 cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Small proline rich protein 2a in benign and malignant liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNAs as novel regulators of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Multifunction protein staphylococcal nuclease domain containing 1 (SND1) promotes tumor angiogenesis in human hepatocellular carcinoma through novel pathway that involves nuclear factor κB and miR-221

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Hypoxia-inducible MiR-182 promotes angiogenesis by targeting RASA1 in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2, and CDC42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA-26a inhibits angiogenesis by down-regulating VEGFA through the PIK3C2α/Akt/HIF-1α pathway in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Imatinib for hepatocellular cancer--focus on pharmacokinetic/pharmacodynamic modelling and liver function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Growth factor receptors and related signalling pathways as targets for novel treatment strategies of hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Pharmacokinetic and clinical phase II trial of imatinib in patients with impaired liver function and advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Laparoscopic cholecystectomy with previous gastrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

An E2F/miR-20a autoregulatory feedback loop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA regulation of a cancer network: consequences of the feedback loops involving miR-17-92, E2F, and Myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA-21 promotes cell proliferation in human hepatocellular carcinoma partly by targeting HEPN1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Aurora-A promotes chemoresistance in hepatocelluar carcinoma by targeting NF-kappaB/microRNA-21/PTEN signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

miR-106b-25/miR-17-92 clusters: polycistrons with oncogenic roles in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

miR-181b promotes hepatic stellate cells proliferation by targeting p27 and is elevated in the serum of cirrhosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Upregulated miR-182 increases drug resistance in cisplatin-treated HCC cell by regulating TP53INP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Hypoxia-inducible microRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA-221 governs tumor suppressor HDAC6 to potentiate malignant progression of liver cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Increased miR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Autophagy suppresses tumorigenesis of hepatitis B virus-associated hepatocellular carcinoma through degradation of microRNA-224.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA-519d targets MKi67 and suppresses cell growth in the hepatocellular carcinoma cell line QGY-7703.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA-550a acts as a pro-metastatic gene and directly targets cytoplasmic polyadenylation element-binding protein 4 in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA-1 inhibits proliferation of hepatocarcinoma cells by targeting endothelin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA-7 arrests cell cycle in G1 phase by directly targeting CCNE1 in human hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Underexpression of miR-34a in hepatocellular carcinoma and its contribution towards enhancement of proliferating inhibitory effects of agents targeting c-MET

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Targeted disruption of Nemo-like kinase inhibits tumor cell growth by simultaneous suppression of cyclin D1 and CDK2 in human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA-124 suppresses growth of human hepatocellular carcinoma by targeting STAT3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA-125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Histone lysine methyltransferase, suppressor of variegation 3-9 homolog 1, promotes hepatocellular carcinoma progression and is negatively regulated by microRNA-125b

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

miR-126 regulates angiogenic signaling and vascular integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MiR-126-3p suppresses tumor metastasis and angiogenesis of hepatocellular carcinoma by targeting LRP6 and PIK3R2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Derepression of c-Fos caused by microRNA-139 down-regulation contributes to the metastasis of human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA-145 suppresses hepatocellular carcinoma by targeting IRS1 and its downstream Akt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Control of mitogenic and motogenic pathways by miR-198, diminishing hepatoma cell growth and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

miR-203 inhibits proliferation of HCC cells by targeting survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Overexpression of miR-218 inhibits hepatocellular carcinoma cell growth through RET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12606

MicroRNA-449 suppresses proliferation of hepatoma cell lines through blockade lipid metabolic pathway related to SIRT1.

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.3892/IJO.2014.2596

MicroRNA-195 functions as a tumor suppressor by inhibiting CBX4 in hepatocellular carcinoma.

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.3892/OR.2015.3734

Identifiers

DOI

10.1111/HEPR.12606

1 reference

4 September 2017

1 reference